|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH PAPER
1 Department of Biochemistry and Biophysics, and 2 The Protein Chemistry Laboratory, Texas A&M University, College Station, Texas 77843, USA
| Abstract |
|---|
|
|
|---|
[Keywords: Vacuole; CLN; CDC42; BEM1; cell size; START]
Received August 5, 2005; revised version accepted August 30, 2005.
Vacuoles in Saccharomyces cerevisiae serve as repositories of metabolites and low molecular weight compounds and are analogous to the lysosomes of animal cells, containing numerous hydrolases (Roberts et al. 1991
; Jones et al. 1997
). The vacuole is a low-copy organelle, and yeast cells typically contain one to three vacuoles. The large size of the vacuolar compartment (
25% of the total cellular volume) (Wiemken and Durr 1974
) and the availability of vacuole-specific vital fluorescent dyes facilitate observations of overall vacuolar morphology. Defects in self (homotypic) fusion of vacuolar vesicles lead to vacuolar fragmentation (Seeley et al. 2002
). Thus, homotypic fusion is very important for vacuolar homeostasis and it can also be evaluated in vitro (Wickner and Haas 2000
). Although daughter cells of certain vacuolar inheritance mutants can be born without a vacuole, they must form a new one before they can pass through a point in late G1 called START and initiate DNA replication and a new round of cell division (Weisman 2003
). A recent report also suggested that in Candida albicans the vacuolar compartment may impact on cell cycle progression and hyphal development (Barelle et al. 2003
). Nonetheless, it is not known how the molecular machinery that regulates cell cycle progression also affects vacuolar biogenesis or vice versa.
In late G1 START completion is mediated by Cdc28p (a cyclin-dependent kinase [Cdk]) in association with one of the G1 cyclins, Cln1,2,3p. Cells lacking all three CLN genes are inviable and cannot complete START (Richardson et al. 1989
). Cln3p functions upstream of Cln1,2p activating the G1/S transcription program (Dirick et al. 1995
), where
200 genes (CLN1,2 among them) are transcribed (Spellman et al. 1998
). Cln3p/Cdc28p phosphorylates Whi5p, a repressor of the G1/S transcription factor SBF, thereby releasing Whi5p from SBF and activating START transcription (Costanzo et al. 2004
; de Bruin et al. 2004
; Schaefer and Breeden 2004
). In addition, our earlier findings provided evidence for a novel function of Cln3p in vacuolar homotypic fusion, separate from its role in G1/S transcription and not shared by other G1 cyclins (Han et al. 2003
).
|
In this report we show that Bem1p is required for vacuolar homotypic fusion and that the overall vacuolar compartment in bem1
cells is enlarged but fragmented, similar to cln3
cells. Furthermore, Bem1p is phosphorylated in a Cln3p-dependent manner at Ser72. A single S72D substitution in Bem1p (which mimics phosphorylation) or overexpression of CDC42 or CDC24 suppresses the vacuolar fragmentation of cln3
cells. Conversely, substituting Ser72 in Bem1p with Ala blocks the ability of Cln3p to promote vacuole fusion, in vivo and in vitro. The results we report here suggest that Cln3p impacts on vacuolar homeostasis through Bem1p and Cdc42p.
| Results |
|---|
|
|
|---|
We had previously shown that Cln3p is required for vacuolar homotypic fusion (Han et al. 2003
). Vacuolar homotypic fusion is composed of several distinct sequential steps: priming, docking, and fusion (Wickner and Haas 2000
). To study the kinetics of the reaction, order of addition experiments can be done, whereby the fusion reaction progressively becomes resistant to the addition of various inhibitors, once the inhibitor-sensitive step has been completed. For example, placement on ice blocks all steps and thus results in a "late-stage" inhibition profile, which is also similar to the GTP-
-S inhibition profile. There are several GTPases involved in more than one step, including the last fusion step, which leads to a late-stage inhibition profile by GTP-
-S (Eitzen et al. 2000
, 2001
). On the other hand, the ionophore FCCP blocks the docking step and it does not significantly inhibit the overall reaction if added late.
Using this approach, we decided to determine the stage of the overall reaction that requires Cln3p for its completion, with cytosol from cells expressing HA-tagged Cln3p. We then added an anti-HA antibody as an inhibitor at various time points during the reaction and measured the overall fusion activity at the end of the 90-min incubation period (Fig. 1). This experiment was done in parallel with several other reactions, to compare the profile of Cln3p withdrawal to the profiles of known fusion inhibitors (Fig. 1). From this analysis, it appears that the reaction becomes resistant to removal of Cln3p with kinetics slightly earlier than the kinetics for FCCP addition (Fig. 1). Thus, once docking is complete, Cln3p is not required for vacuolar homotypic fusion.
|
cells, supplemented with Cln3p expressed in bacteria (Fig. 1C). Addition of recombinant Cln3p, but not of the unrelated control protein Dcr2p (Pathak et al. 2004
Bem1p impacts on vacuolar biogenesis, downstream of Cln3p
To understand Cln3p's vacuolar function, we reasoned that one of the numerous known regulators of homotypic fusion might be targeted by Cln3p. Possible downstream effectors of Cln3p/Cdc28p in vacuolar homotypic fusion may display the following properties: Loss-of-function mutations should lead to vacuolar and overall cell size enlargement, loss-of-function mutations should lead to vacuolar fragmentation, and the putative effectors should be Cdk targets. Recent genome-wide studies focused on these properties, namely, altered cell size (Jorgensen et al. 2002
; Zhang et al. 2002
), fragmented vacuolar morphology (Seeley et al. 2002
), and proteins that are phosphorylated by Cdc28p in whole-cell extracts (Ubersax et al. 2003
). There are >100 gene products in each data set (Fig. 2A). For example, there were 181 proteins that were significantly phosphorylated by Clb2p/Cdc28p (with a P-score
2, which is the logarithm of the amount of phosphate incorporated per nanogram of protein). Yet, only Cln3p itself and Bem1p were present in all three data sets (Fig. 2A).
Using the in vitro fusion assay, we found that reactions with cytosol from BEM1-TAP cells in the presence of inhibitory rabbit IgG (which targets the TAP domain) had significantly reduced fusion activity (Fig. 2B). Loss of Bem1p or Cln3p also leads to vacuolar fragmentation in
40-60% of the cells (see Fig. 3A,B; Seeley et al. 2002
; Han et al. 2003
). Furthermore, cells lacking BEM1 were larger overall (
40%) (Figs. 2, 3) than wild-type cells and, importantly, their vacuolar compartment was also disproportionately enlarged (about twofold) (Figs. 2, 3). Finally, Cdc28p readily phosphorylated Bem1p (P-score = 3.4) in the phosphorylation assays by Ubersax et al. (2003
). Consequently, we decided to evaluate Bem1p as a putative Cln3p/Cdc28p effector in vacuolar biogenesis.
To test whether Cln3p might mediate its effects in vacuolar biogenesis through Bem1p, we measured the overall cell size and vacuolar size of CLN3 and BEM1 mutant combinations and also microscopically examined their vacuolar morphology. Loss of Cln3p or Bem1p leads to cellular and vacuolar enlargement and vacuolar fragmentation (Fig. 3). Conversely, cells expressing a stabilized form of Cln3p from the dominant gain-of-function CLN3-2D allele are smaller overall (Cross 1988
), and their vacuolar compartment is also smaller (see Fig. 3A; Han et al. 2003
). However, the CLN3-2D allele was unable to reduce cell and vacuole size in the absence of Bem1p (Fig. 3A). Furthermore, combined loss of Bem1p and Cln3p did not lead to an additive cellular or vacuolar enlargement or vacuolar fragmentation (Fig. 3B). These results are consistent with the idea that Bem1p is required for Cln3p's effects on cell and vacuole size, and that Bem1p and Cln3p do not affect vacuolar biogenesis through separate independent pathways.
Bem1p is phosphorylated in a Cdk-dependent manner
It has been previously mentioned in an earlier report that Bem1p might be a phosphoprotein, because phosphatase treatment leads to faster migration of Bem1p during SDS-PAGE (Leeuw et al. 1995
). Indeed, immunoprecipitated TAP-tagged Bem1p migrated faster upon phosphatase treatment (Fig. 4A). Bem1p has four potential Cdk phosphorylation sites: two [ST]-P-X-[KR] sites at Thr51 and Ser72 and two [ST]-P sites at Thr26 and Ser60, respectively. As a first step toward establishing possible Cdk-mediated phosphorylation events, we asked whether an antibody directed against phosphorylated [ST]-P recognized Bem1p immunoprecipitated from cell extracts. From these cell extracts we sequentially immunoprecipitated Bem1p-TAP using IgG and calmodulin beads (Fig. 4B). The immunoprecipitated protein was readily recognized by the PAP reagent, via the protein A domain (Fig. 4B). To use the anti-phospho-[ST]-P antibody, after immunoprecipitations with IgG beads, we cleaved the immunoprecipitated product with TEV protease to remove the protein A part of the TAP epitope. Immunoblotting with the anti-phospho-[ST]-P antibody recognized the cleaved Bem1p-CBP (which now lacks the protein A part of the TAP tag) (Fig. 4B). Recognition by the anti-phospho-[ST]-P antibody was phosphorylation dependent, because the signal was significantly reduced after treatment with phosphatase (Fig. 4C). When normalized for Bem1p levels using an antibody that recognizes the remaining part of the TAP tag after TEV cleavage, treatment with phosphatase removed >70% of the signal (Fig. 4C, bottom).
|
40% of the activity when DMSO alone was added (Fig. 4E). Together, all of the above results support the hypothesis that Bem1p is phosphorylated in a Cdc28p-dependent manner in vivo.
Ser72 is critical for Bem1p's role in vacuolar homeostasis
We then examined whether the Bem1p potential Cdk phosphorylation sites are conserved in other Saccharomyces species (Cliften et al. 2003
; Kellis et al. 2003
) and in a couple of Candida species for which genome information is available (Fig. 5A). Not surprisingly, all the sites are conserved in the sensu stricto Saccharomyces species (S. mikatae, S. kudriavzevii, S. paradoxus, and S. bayanus). S. castellii is a more distantly related sensu lato Saccharomyces species, and alignment of Bem1p to its ortholog in this species is likely to be more useful (Cliften et al. 2003
). In S. castellii only positions 26 and 72 are conserved, while in the two Candida species positions 51 and 72 are conserved (Fig. 5A). The extreme N terminus of the C. albicans Bem1p does not show significant conservation with the S. cerevisiae Bem1p, and the highlighted position may not correspond to Ser51. Overall, the only conserved site in all of these cases is Ser72 (Fig. 5A), which is a preferred [ST]-P-X-[KR] Cdk consensus site. Ser72 also represents the first amino acid residue of the SH3-1 domain, which spans from position 72 to 132, based on PROSITE software predictions (Gattiker et al. 2002
).
|
or cln3
cells expressing these Bem1p mutants from low-copy plasmids as C-terminal cMyc fusions (Fig. 5B). The S72A and S72D mutants were expressed at levels similar to the wild-type cMyc-tagged Bem1p, and their subcellular localization was indistinguishable from wild type (data not shown). We noticed that introduction of the otherwise wild-type cMyc-tagged Bem1p on a low-copy centromeric plasmid only partially suppressed the vacuolar fragmentation of bem1
cells (Fig. 5B). The plasmid is clearly functional because it does suppress the bud emergence defect of bem1
cells (see Fig. 7, below; Irazoqui et al. 2003
cells (Fig. 8D, below).
Nonetheless, it is important to note that the fact that wild-type cMyc-tagged Bem1p from a low-copy plasmid only partially suppressed vacuolar fragmentation conveniently allows one to evaluate the effects of the S72D substitution even in bem1
(but CLN3+) cells. It was clear that S72D Bem1p suppressed vacuolar fragmentation better than wild-type Bem1p, and, conversely, the S72A Bem1p mutant did not suppress at all the vacuolar fragmentation of bem1
cells (Fig. 5B,C). Because the S72A mutant is functional in bud emergence (see below, Fig. 7), the lack of suppression in vacuolar fragmentation is unlikely to be due to the production of a nonfunctional unfolded protein. Finally, introduction of the S72D, but not the S72A, Bem1p mutant in cln3
cells also significantly suppressed their vacuolar fragmentation (Fig. 5B,C).
To further test the role of Ser72, we overexpressed Cln3p in cells carrying wild-type or Ser72 Bem1p mutants (Fig. 5D). We found that cells carrying both the CLN3-2D and BEM1-S72A alleles had fragmented vacuolar morphology (Fig. 5D). Thus, the S72A substitution blocks the ability of Cln3p to promote vacuole fusion in vivo. We then performed in vitro fusion reactions using cytosol from cells lacking both Cln3p and Bem1p, supplemented with various combinations of recombinant Cln3p, Bem1p, Bem1p-S72A, and Bem1p-S72D (Fig. 5E). The highest activity was observed upon addition of Bem1p-S72D with or without Cln3p, and the lowest upon addition of Bem1p-S72A. Also, addition of Cln3p alone or with Bem1p-S72A did not increase fusion activity (Fig. 5E). Therefore, these in vitro results completely support our in vivo evidence that Cln3p requires Bem1p to promote fusion. Furthermore, the S72A substitution in Bem1p blocks fusion, while the S72D mutation promotes it. Interestingly, addition of wild-type Bem1p also increased fusion activity in the absence of Cln3p, albeit not to the same level as Bem1p-S72D. Thus, it is possible that in the absence of Cln3p, when large amounts of exogenous Bem1p are added, Bem1p can still be modified in these extracts, perhaps by other cyclin/Cdk complexes. Taken together, our results from the in vitro fusion assays are in very good agreement with our in vivo evidence, and suggest that Cln3p and Bem1p play direct roles in vacuole fusion, with Bem1p acting downstream of Cln3p.
|
and bem1
cells in vivo and in vitro, while the S72A mutant did not, it is reasonable to conclude that even if additional sites are phosphorylated, phosphorylation of Ser72 has the most significant biological consequences for vacuolar biogenesis.
We then used 2D gel electrophoresis to better resolve putative Bem1p isoforms (Fig. 6A). Indeed, an acidic isoform present in wild-type Bem1p (Fig. 6A, top panel) was absent in cells lacking Cln3p (Fig. 6A, middle panel) or in cells carrying Bem1p-S72A (Fig. 6A, bottom panel). We also noticed that Bem1p-S72A migrated slightly faster than wild-type Bem1p in standard one-dimensional SDS-PAGE, similar to wild-type Bem1p in cln3
cells (Fig. 6B). Together, these results strongly suggest that Bem1p is phosphorylated at Ser72 in a Cln3p-dependent manner in vivo.
Finally, we examined whether Bem1p expressed in bacteria could be phosphorylated in vitro. For this experiment we overexpressed CLN3 from a high-copy plasmid carrying epitope-tagged CLN3 under the control of a galactose-inducible promoter. It has been previously shown that overexpression of Cln3p allows for the recovery of detectable Cln3p-associated kinase activity against histone H1, and that most of that activity is Cdc28p-dependent (Tyers et al. 1992
, 1993
). Indeed, the immunoprecipitated Cln3p had associated kinase activity against recombinant Bem1p, albeit to significantly lower levels compared with histone H1 (Fig. 6C). We also performed similar reactions using commercially available preparations of human Cdc2/cyclinB and Cdk2/cyclinA complexes. Surprisingly, Cdc2/cyclinB apparently phosphorylated Bem1p (Fig. 6C). Whether this reflects "background" nonspecific levels of activity of this preparation is unclear at this point. Note that although the Cdc2 signal appears stronger than the signal from Cln3p (Fig. 6C), the commercial Cdc2 preparation we used was much more active against histone H1 than the Cln3p-associated activity we obtained from yeast cells.
|
|
Since Bem1p was originally identified for its role in bud emergence (Bender and Pringle 1991
), we next examined whether our Bem1p Ser72 mutants have phenotypes associated with bud emergence. To quantify the bud emergence defect we measured the frequency of unbudded cells containing spindles. The S72A mutant was fully functional in bud emergence (Fig. 7), in contrast to its total lack of complementing activity in vacuole fusion (Fig. 5). Interestingly, the S72D substitution did not fully complement the bud emergence defect of bem1
cells (Fig. 7). Thus, while phosphorylation of Ser72 promotes vacuole fusion, it is not required for and it might even negatively affect bud emergence.
Overexpression of Cdc42p or Cdc24p suppresses the vacuolar fragmentation of cln3
cells
We next examined whether Cln3p's requirement for vacuolar homotypic fusion might reflect perturbations of Cdc42p activity, since Bem1p is a well-established regulator of Cdc42p, and Cdc42p is also required for the docking step of vacuolar homotypic fusion (Eitzen et al. 2001
; Muller et al. 2001
). To perhaps bypass the requirement for Cln3p, we activated the Cdc42p GTPase cycle by overexpressing wild-type CDC42, or its exchange factor CDC24, in cln3
cells and evaluated their vacuolar morphology. Remarkably, overexpression of CDC42 or CDC24 completely suppressed the fragmented vacuolar morphology of cln3
cells (Fig. 8A,B). On the other hand, overexpression of CDC42 did not significantly suppress the vacuolar fragmentation of bem1
cells (Fig. 8B). CDC24 overexpression weakly suppressed the vacuolar fragmentation in bem1
cells (Fig. 8B). Overall, overexpression of Cdc42p, in the presence of Bem1p, is sufficient to bypass the requirement for Cln3p in vacuole fusion.
Furthermore, in the in vitro fusion assay, addition of Cdc42p did not rescue the fusion defect of bem1
cytosolic extracts (Fig. 8C), suggesting again that Bem1p is required for Cdc42p to promote fusion. Interestingly, when the extracts were supplemented with Bem1p-S72A together with Cdc42p there was an increase in fusion activity (
60%) (Fig. 8C), but not to the same extent as when the extracts were supplemented with Bem1p-S72D (see Fig. 5E).
We next examined several other Bem1p amino acid substitutions at positions that are important for Bem1p's biological roles (Irazoqui et al. 2003
) for their ability to suppress vacuolar fragmentation of bem1
cells (Fig. 8D). For example, a P208L substitution affects interactions with various effectors and scaffolds, P355A interferes with a postulated conformational change of Bem1p, R369A inhibits interactions with phosphoinositides, and K482A affects interaction with Cdc24p (Irazoqui et al. 2003
). The R369A substitution did not have any effect (Fig. 8D), suggesting perhaps that lipid interactions are not important for Bem1p's function in vacuolar homotypic fusion. To varying degrees, the other Bem1p mutants also significantly suppressed vacuolar fragmentation of bem1
cells (Fig. 8D). Notably, the weakest suppression, albeit still significant, was observed with the P208L substitution (Fig. 8D), which affects protein-protein interactions through the SH3-2 domain (Irazoqui et al. 2003
).
|
cells. When we followed the "old" vacuolar compartment synthesized in previous cell divisions, we found that bem1
and wild-type cells equally distribute their vacuoles between the mother and the bud (Fig. 8E), unlike cln3
cells, which have a weak but measurable defect (Fig. 8E; Han et al. 2003
cells (data not shown). Overall, these results suggest that it is unlikely that the mechanism we describe here linking Cln3p and Bem1p significantly affects vacuole segregation. | Discussion |
|---|
|
|
|---|
We were initially led to Bem1p because bem1
cells are large and their vacuolar compartment is also enlarged and fragmented, similar to the situation in cln3
cells (Fig. 2; Han et al. 2003
). The experiments we report here suggest that Bem1p is phosphorylated in a Cdk-dependent manner. The biological significance of Ser72 phosphorylation is underscored by the fact that a substitution to Asp that probably mimics phosphorylation suppresses vacuolar fragmentation, while an Ala substitution does not (Fig. 5). Our data strongly point to the link between Cln3p and modification of Ser72 (Fig. 6). In vitro, however, it appears that multiple Cdk complexes can phosphorylate Bem1p. Addition of Bem1p from bacteria can still promote vacuole fusion in vitro, in the absence of Cln3p (Fig. 5E), suggesting that other cyclin/Cdk complexes might also be able to phosphorylate this exogenous pool of Bem1p. Furthermore, Clb2p/Cdc28p was previously shown to phosphorylate Bem1p (Ubersax et al. 2003
) in vitro. This result was further extended in a follow-up study, where Loog and Morgan (2005
) found that Clb5p/Cdc28p and Clb2p/Cdc28p phosphorylated Bem1p with equal efficiency. Nonetheless, in living cells Cln3p certainly plays a unique role in vacuolar biogenesis because loss of any other cyclin does not lead to vacuolar fragmentation (Seeley et al. 2002
; Han et al. 2003
).
While it is thought that overall vacuolar biogenesis is the result of reciprocal control between vacuole fusion and fission (Peters et al. 2004
), there is no evidence that either of these processes oscillate in the cell cycle. Vacuolar inheritance is thought to be coordinated with the cell cycle and we have previously reported that loss of Cln3p leads to mild defects in vacuolar segregation (Fig. 8E; Han et al. 2003
), but there are no such defects in bem1
cells (Fig. 8E). Thus, although the mechanism we describe here linking Cln3p with Bem1p certainly impacts on the "steady-state" overall vacuolar homeostasis, it may not necessarily impart an oscillatory feature to it.
On the other hand, Cln3p's vacuolar roles strongly affect the cell size phenotypes associated with CLN3 mutations (see Fig. 3; Han et al. 2003
). As we have discussed previously (Han et al. 2003
), this does not extend to all cell size mutants. Vacuolar enlargement is usually accompanied by cellular enlargement (Efe et al. 2005
) but the converse is not necessarily true and not all large cell size mutants have large vacuoles. This is exemplified in double mutant cln1,2
cells, which are large overall although they have small vacuoles (Han et al. 2003
). A general correlation between vacuolar fragmentation and cell size also does not seem to exist (Fig. 2A). All these observations suggest that Cln3p's role in vacuole fusion is separate from and probably does not impact on the other function of Cln3p in accelerating initiation of DNA replication.
How might cyclin-dependent phosphorylation of Bem1p impact on vacuole fusion? Cdc42p is involved in actin dynamics (Etienne-Manneville 2004
; Irazoqui and Lew 2004
) and vacuole fusion (Eitzen et al. 2001
; Muller et al. 2001
). Importantly, the temporal requirement of Cln3p or Cdc42p for fusion appears to be similar. Loss of either Cln3p or Cdc42p leads to vacuolar fragmentation, but once the docking step of fusion is completed neither Cln3p (Fig. 1) nor Cdc42p (Eitzen et al. 2001
; Muller et al. 2001
) are required anymore for fusion. While it is clear that noncytoskeletal actin is found on the surface of vacuoles and remodeling of this actin pool is required for vacuole fusion (Eitzen et al. 2002
), it is not known how it contributes to fusion. This requirement is distinct from the actin cytoskeleton-dependent processes of vacuole segregation (Weisman 2003
; Pruyne et al. 2004
). Since we find no evidence for a defect in vacuolar segregation in bem1
cells (Fig. 8D), there is no reason to think that the cyclin-dependent phosphorylation of Bem1p we describe here affects this process. Consequently, our data placing Bem1p downstream of Cln3p (Figs. 3, 5) and the ability of Cdc42p to suppress vacuole fragmentation in cln3
cells (Fig. 8) probably reflect the noncytoskeletal role of actin for vacuole fusion that has been proposed by the Wickner and Mayer laboratories (Eitzen et al. 2001
, 2002
; Muller et al. 2001
).
Organelle-bound actin could also act as a fusion barrier, which must transiently disassemble for vesicles to dock, while later promoting actin assembly is thought to somehow help the docked vesicles to finally fuse (Eitzen 2003
). Based on chemical inhibition experiments, it appears that the actin depolymerizing drug latrunculin B inhibits the last fusion step of vacuole homotypic fusion (Eitzen et al. 2001
). Interestingly, the F-actin binding and stabilizing drug jasplakinolide inhibited the docking step of fusion only, and not the last latrunculin B-sensitive step (Eitzen et al. 2001
). Given that Cln3p (Fig. 1) and Cdc42p (Eitzen et al. 2001
; Muller et al. 2001
) are not required after the docking step of fusion, the fact that Ser72 of Bem1p has distinct and even opposing roles in vacuole fusion versus bud emergence (Figs. 5, 7), and the fact that other Bem1p mutants that affect bud emergence do not affect vacuole fusion (Fig. 8), it is possible that the effects we are observing reflect the "actin as a barrier" model of fusion (Eitzen 2003
).
Does cyclin-dependent phosphorylation of Bem1p affect other Bem1p-regulated processes? The S72A substitution is incapable of suppressing vacuolar fragmentation in bem1
cells, but it is still fully active in bud emergence (Figs. 5, 7). On the other hand, the S72D substitution fully suppresses vacuole fragmentation, but it only partially suppresses bud emergence (Figs. 5, 7). These results suggest that Bem1p has distinct roles in bud emergence and vacuole fusion. While presumably locking Ser72 to the phosphorylated state (in the S72D mutant) suffices to suppress vacuolar fragmentation (Fig. 5), it might adversely affect bud emergence (Fig. 7).
The notion that Bem1p's roles in vacuole fusion and bud emergence may be distinct is also suggested by the fact that other Bem1p mutants (for example, the K482A mutant) that were shown to be unable to suppress bud emergence defects (Irazoqui et al. 2003
) retain full complementing ability in vacuole fusion (Fig. 8D). Even the P208L mutant, which cannot complement bud emergence (Irazoqui et al. 2003
), partially suppressed vacuolar fragmentation (Fig. 8D). The P208L mutant affects interactions between the SH3-2 domain of Bem1p with various effectors, including the Cla4p kinase. Interestingly, loss of Cla4p leads to vacuolar fragmentation (Seeley et al. 2002
), and it is possible that interactions mediated by the SH3-2 domain of Bem1p might be important for vacuole fusion, explaining the incomplete suppression of vacuolar fragmentation we got from the P208L mutant (Fig. 8D).
In any case, since the actin remodeling necessary for vacuole fusion is not the same as the rearrangement of the actin cytoskeleton that takes place during bud emergence, probably identical mechanisms/effectors do not operate in both processes. It should also be noted that while Cln1p and Cln2p have established roles in bud emergence (Gulli et al. 2000
; Bose et al. 2001
; Moffat and Andrews 2004
), they do not affect vacuole fusion (Han et al. 2003
). Finally, although there are no known protein-protein interactions mediated by the SH3-1 domain of Bem1p, it is possible that Ser72 might impact on vacuole fusion through interactions with effectors that have specific roles in fusion. Given the scaffold role of Bem1p and the fact that addition of Cdc42p in the presence of the Bem1p-S72A mutant did not promote fusion as efficiently as the Bem1p-S72D mutant alone (cf. Figs. 8C and 5E), it is possible that phosphorylation of Ser72 is important for some kind of protein-protein interactions that promote vacuole fusion. Future experiments need to address in full detail the mechanisms that account for the differences between Bem1p's roles in vacuole fusion and bud emergence.
| Materials and methods |
|---|
|
|
|---|
Cell cultivation, media, and yeast molecular biology techniques were performed as described by Kaiser et al. (1994
), unless otherwise indicated. The strains and plasmids used in this study are listed in Tables 1 and 2, respectively. To generate the bem1
cln3
strain (SMY01) we disrupted one CLN3 copy in diploid bem1
cells as described previously (Polymenis and Schmidt 1997
). The resulting heterozygote was sporulated, and the segregants were obtained by random spore analysis (Kaiser et al. 1994
). All the single cyclin deletions and the bem1
strain in the BY4741 background were obtained by sporulation of the corresponding homozygous diploid deletion strains distributed from Research Genetics. The phenotypes reported for each strain were obtained after examining several independent transformants or segregants for the strain in question.
|
|
To construct plasmids for bacterial expression, we digested the BG1805-based plasmids (purchased from Open Biosystems; see Table 2) with AgeI, which cuts once in the GAL1 promoter all the BG1805 plasmids used here. The digested plasmids were then transformed into a Ura- yeast strain for gap repair together with an oligonucleotide that encodes the arabinose PBAD promoter and ribosome-binding site (Guzman et al. 1995
) (GAL1-PBAD-FWD, 5'-CGGGAACGGATTAGAAGCCGCCGAGCG GGTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCA TACCCGTTTTTTTGGATGGAGTGAATATACCTCTATAC TTTAACGTCAAGGAGAA-3'). GAL1-PBAD-FWD at its 5'end carries sequences complementary to GAL1 sequences upstream of the AgeI site, and at its 3' end sequences complementary immediately upstream of the ATG start codon of the ORF in the BG1805 plasmids, which correspond to the bacteriophage
attR1 site.
The mutant plasmid derivatives were sequenced to verify the introduced mutation and the absence of any other mutations at the Genome Technologies Laboratory of Texas A&M University.
Vacuolar morphology and size
For microscopic examination of vacuolar membranes the cells were stained with N-(3-triethylammoniumpropyl)-4-(6-[4-diethylamino]phenylhexatrienyl)pyridinium dibromide, FM4-64, from Molecular Probes, as described by Han et al. (2003
), and then examined microscopically with a Nikon Eclipse TS100 inverted fluorescence microscope.
Vacuolar size was evaluated by flow cytometry after staining with the vital vacuolar stain 5' (and 6')-carboxy-2',7'-dichlorofluorescein diacetate, CDCFDA, from Molecular Probes as described previously (Han et al. 2003
).
The mean cell volume of live unfixed samples was measured using a Beckman Coulter Z2 Channelyzer. The data were analyzed using the manufacturer's AccuComp software. The geometric mean is indicated in each case.
In vitro vacuole fusion
Cytosol and vacuoles were prepared and used as described previously (Mayer et al. 1996
; Han et al. 2003
). Briefly, to measure fusion activity the reaction mixture was equally split, and to each aliquot the same volume of buffer with inhibitor (or antibody) was added. Buffer-added aliquots were incubated at 27°C or on ice, the fusion activities of which were measured after 90 min and set as 100% or 0% fusion activity, respectively. The inhibitor-added aliquot was incubated at 27°C for the same time and its fusion activity was measured to evaluate the relative fusion activity.
Protein analysis
Unless otherwise indicated, the gels for SDS-PAGE (Laemmli 1970
) contained 8% of a 29:1 acrylamide/bis-acrylamide solution. Immunoprecipitations and TEV cleavage of TAP-tagged Bem1p were performed according to the protocols and reagents recommended by Rigaut et al. (1999
). Briefly, 5 x 109 cells of untagged or TAP-tagged BEM1 cells from the exponential phase of growth were used. Cell extracts were prepared in the presence of protease and phosphatase inhibitor cocktails (Sigma). After the first immunoprecipitation with IgG-agarose beads, the beads were washed twice with RIPA buffer and once with TEV reaction buffer. Eighty units of TEV for 30 min at 30°C were used to cleave the protein A domain. The phosphatase experiment shown in Figure 4A was done as described previously (Liakopoulos et al. 2003
). For the phosphatase experiments in Figure 4C, Bem1p-CBP on calmodulin beads was washed three times with RIPA buffer and once with
-phosphatase reaction buffer. Then 500 U of
-phosphatase and 10x of protease inhibitor cocktail were added and incubated at 30°C for 30 min in the presence or absence of 10x phosphatase inhibitor cocktail.
For protein surveillance, cell extracts were prepared using a urea extraction buffer as described by Ubersax et al. (2003
). The differences in Bem1p's electrophoretic mobility in 1D SDS-PAGE are better resolved if the samples are desalted prior to electrophoresis (using a kit from Pierce, according to their instructions), and electrophoresis is performed at a constant voltage of 70 V (instead of the typical 200 V applied to minigels).
Two-dimensional gel electrophoresis was performed using carrier ampholytes (pH 4-6; GE Healthcare) in acrylamide tubes according to the method of O'Farrell (1975
). Seven-centimeter-long tube gels containing 0.5% ampholytes were focused for
1000 volt hours without prefocusing. The tubes were extruded and soaked, sequentially, in SDS sample buffer containing dithiothreitol or iodoacetamide. The tube gels containing the reduced and alkylated proteins were subsequently placed on top of 8% polyacrylamide slab minigels and subjected to SDS PAGE (Laemmli 1970
). Prior to immunostaining, the proteins were electroblotted onto PVDF membranes (Immobilon Psq; Millipore) at 100-200 mA overnight using 10 mM CAPS, 10% methanol (pH 11).
For immunostaining, protein A fusion proteins were detected with the peroxidase-anti-peroxidase (PAP) soluble complex reagent from Sigma. The anti-Pgk1p antibody was from Molecular Probes. The anti-phospho-[ST]P, anti-CBP, anti-HA, and anti-Myc antibodies were from Abcam. The horseradish peroxidase-conjugated secondary antibodies used for immunoblotting were also from Abcam. All antibodies were used at the dilutions recommended by the manufacturers. The blots were processed with reagents from Pierce.
Bacterial expression
The pBAD-based plasmids were transformed into Escherichia coli (strain XL1-Blue). For protein expression we followed previously published procedures (Guzman et al. 1995
). From 50-100-mL cultures we obtained soluble protein from all the constructs we describe here. The exception was Cln3p, which required larger cultures (0.5l-1 L) because the majority of the recombinant protein appeared to be insoluble. We purified the recombinant proteins through their 6xHis epitope, using TALON Co2+ affinity beads (BD Biosciences), according to the manufacturer's instructions.
Kinase assays
Human Cdc2/cyclin B and Cdk2/cyclin A were from New England Biolabs, and used at 5 U per reaction. Cln3p-associated activity was obtained from yeast cells (strain W303a) carrying plasmid BG1805-CLN3 (see Table 2), using TALON Co2+ affinity beads (BD Biosciences), according to the manufacturer's instructions. The Cln3p-associated activity was from
1010 cells initially grown in raffinose, but 4 h prior to harvesting, the culture was induced with 2% galactose. Histone H1 was from Sigma and used as a substrate at 5 µg per reaction. Bem1p was obtained from bacteria as described above. The reactions also contained 5 µCi [
-32P]ATP, 100 µM ATP, 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, and 0.01% Brij 35. All the reactions (30 µL total volume) were performed at room temperature for 20 min.
Immunofluorescence microscopy
Unless otherwise indicated, we followed the protocols of the Botstein laboratory as described at http://genome-www.stanford.edu/group/botlab. DAPI, 4'6-diamidino-2-phenylindole, was from Sigma. The anti-tubulin primary antibody and the secondary FITC-conjugated antibody were from Abcam. For the experiment shown in Figure 7, the cells were grown at 37°C to exacerbate the bud emergence defect of bem1
cells. The samples were examined with a Nikon Eclipse TS100 inverted fluorescence microscope.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
3 Corresponding author.
E-MAIL polymenis{at}tamu.edu; FAX (979) 845-9274. ![]()
| References |
|---|
|
|
|---|
Bender, A. and Pringle, J.R. 1991. Use of a screen for synthetic lethal and multicopy suppressee mutants to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 11: 1295-1305.
Bishop, A.C., Ubersax, J.A., Petsch, D.T., Matheos, D.P., Gray, N.S., Blethrow, J., Shimizu, E., Tsien, J.Z., Schultz, P.G., Rose, M.D., et al. 2000. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407: 395-401.[CrossRef][Medline]
Bose, I., Irazoqui, J.E., Moskow, J.J., Bardes, E.S., Zyla, T.R., and Lew, D.J. 2001. Assembly of scaffold-mediated complexes containing Cdc42p, the exchange factor Cdc24p, and the effector Cla4p required for cell cycle-regulated phosphorylation of Cdc24p. J. Biol. Chem. 276: 7176-7186.
Cliften, P., Sudarsanam, P., Desikan, A., Fulton, L., Fulton, B., Majors, J., Waterston, R., Cohen, B.A., and Johnston, M. 2003. Finding functional features in Saccharomyces genomes by phylogenetic footprinting. Science 301: 71-76.
Costanzo, M., Nishikawa, J.L., Tang, X., Millman, J.S., Schub, O., Breitkreuz, K., Dewar, D., Rupes, I., Andrews, B., and Tyers, M. 2004. CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell 117: 899-913.[CrossRef][Medline]
Cross, F.R. 1988. DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae. Mol. Cell. Biol. 8: 4675-4684.
de Bruin, R.A., McDonald, W.H., Kalashnikova, T.I., Yates III, J., and Wittenberg, C. 2004. Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5. Cell 117: 887-898.[CrossRef][Medline]
Dirick, L., Bohm, T., and Nasmyth, K. 1995. Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. EMBO J. 14: 4803-4813.[Medline]
Efe, J.A., Botelho, R.J., and Emr, S.D. 2005. The Fab1 phosphatidylinositol kinase pathway in the regulation of vacuole morphology. Curr. Opin. Cell Biol. 17: 402-408.[CrossRef][Medline]
Eitzen, G. 2003. Actin remodeling to facilitate membrane fusion. Biochim. Biophys. Acta 1641: 175-181.[Medline]
Eitzen, G., Will, E., Gallwitz, D., Haas, A., and Wickner, W. 2000. Sequential action of two GTPases to promote vacuole docking and fusion. EMBO J. 19: 6713-6720.[CrossRef][Medline]
Eitzen, G., Thorngren, N., and Wickner, W. 2001. Rho1p and Cdc42p act after Ypt7p to regulate vacuole docking. EMBO J. 20: 5650-5656.[CrossRef][Medline]
Eitzen, G., Wang, L., Thorngren, N., and Wickner, W. 2002. Remodeling of organelle-bound actin is required for yeast vacuole fusion. J. Cell Biol. 158: 669-679.
Etienne-Manneville, S. 2004. Cdc42The centre of polarity. J. Cell Sci. 117: 1291-1300.
Gattiker, A., Gasteiger, E., and Bairoch, A. 2002. Scan Prosite: A reference implementation of a PROSITE scanning tool. Appl. Bioinformatics 1: 107-108